digital health companies glp-1 programs research2guidance Found Health Launches GLP-1 Microdosing

"Vanuatu kava cleared for European market"

Medications based on glucagon-like peptide 1 pathways are an efficient drug treatment for people with obesity, often eliciting rapid and pronounced weight loss

In one clinical trial, carnitine reversed hyperthyroidism by acting as a peripheral antagonist of thyroid hormone action (3)

Neuroendocrinology 66 : 393408 Acuna-Goycolea C and van den Pol AN (2005) Peptide YY336 inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis

Current evidence shows: Research is ongoing to determine how newer oral formulations will compare long-term

Verify current regulatory status, as it continues to evolve